
Cyclosporine Capsules
Form: Capsules
Strength: 25 mg, 50 mg, 100 mg
Reference Brands: Neoral, Sandimmune, Restasis, Celexet(US)
Category: Immune Disorder
Cyclosporine capsules, marketed as Neoral and Sandimmune, are approved in the US by the FDA and in the EU via EMA for preventing transplant rejection and autoimmune disorders. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regulatory compliance is essential for the safe, effective, and timely approval of cyclosporine capsules worldwide, supporting optimal transplant and autoimmune patient care.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Belimumab prefilled syringe
Strength: 200 mg/ten 1 mL for SQ; 10 mg/mL for IV
Form: Subcutaneous (SC) and intravenous (IV) Prefilled syringe
Reference Brands: Benlysta(US & EU)
View Details Get EnquiryAnakinra injection
Strength: 100 mg/mL
Form: Injection(SQ)
Reference Brands: Kinerso, Kineret(US)
View Details Get EnquiryIVIG (Intravenous Immunoglobulin) solution
Strength: 5% or 10%
Form: Intravenous infusion
Reference Brands: Gammagard (Gamunex-C, Flebogamma),Privigen, Octagam, Gamunex-C(US)
View Details Get EnquiryUstekinumab Injection
Strength: SQ:: 45 mg, 90 mg; IV: 130 mg/vial
Form: SQ and IV injection
Reference Brands: Stelara(US)
View Details Get Enquiry